James Paul Scopa's Net Worth
$2.86 Million
Who is James Paul Scopa?
James Paul Scopa has an estimated net worth of $2.86 Million. This is based on reported shares across multiple companies, which include Radius Health, Inc., Pacira Pharmaceuticals, Inc., MEMORY PHARMACEUTICALS CORP, PEPLIN INC, TriVascular Technologies, Inc., DICE Therapeutics, Inc., Verastem, Inc., Syndax Pharmaceuticals Inc, Adverum Biotechnologies, Inc., Aligos Therapeutics, Inc., ARATANA THERAPEUTICS, INC., Conatus Pharmaceuticals Inc, Epizyme, Inc., Cerecor Inc., and CHIASMA, INC.
SEC CIK
James Paul Scopa's CIK is 0001356950
Past Insider Trading and Trends
2021 was James Paul Scopa's most active year for acquiring shares with 7 total transactions. James Paul Scopa's most active month to acquire stocks was the month of May. 2023 was James Paul Scopa's most active year for disposing of shares, totalling 6 transactions. James Paul Scopa's most active month to dispose stocks was the month of July. 2023 saw James Paul Scopa paying a total of $149,999.84 for 334,624 shares, this is the most they've acquired in one year. In 2022 James Paul Scopa cashed out on 30,719 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $19.1
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.17M |
—
|
—
| 2.17M |
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARATANA THERAPEUTICS, INC. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.90% | -600.00K |
$20.02 | -$12,012,000.00 | 2.75M |
Mar 10
| |||
Form 4
| -19.93% | -872.70K |
—
|
—
| 3.51M |
Mar 3
| |||
Form 4
| +944.84% | 3.93M |
$6.00 |
—
| 4.35M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cerecor Inc. (AVTX) Snapshot price: $7.25
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 595.44K |
—
|
—
| 595.44K |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MEMORY PHARMACEUTICALS CORP No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.14M |
$0.61 | -$8,624,785.73 |
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
| 14.24M |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
| 14.24M |
Jun 30
| |||
Form 4
| -0.19% | -27.60K |
$2.10 | -$57,960.00 | 14.14M |
Sep 14
| |||
Form 4
| -0.51% | -72.18K |
$2.13 | -$153,731.06 | 14.17M |
Sep 12 - Sep 13
| |||
Form 4
| +25.00% | 2.85M |
$1.33 | $3,787,512.82 | 14.24M |
Feb 12
| |||
Form 4
| +25.51% | 2.32M |
$1.11 | $2,569,817.61 | 11.39M |
Dec 18
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verastem, Inc. (VSTM) Snapshot price: $2.44
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +105.17% | 2.03M |
$10.00 | $1,000,000.00 | 3.97M |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||